Overview
Mohamed Ouf practices practicing medicine in Cairo, Egypt.
His clinical expertise encompasses Progressive Hemifacial Atrophy, Cavernous Lymphangioma, and Facial Paralysis.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mohamed O. Ouf
Is Mohamed O. Ouf a top-rated expert for Progressive Hemifacial Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Mohamed O. Ouf is classified as an Experienced expert for Progressive Hemifacial Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mohamed O. Ouf participate in research or clinical trials?
Yes. Mohamed O. Ouf has published 8 articles and abstracts on conditions like Progressive Hemifacial Atrophy. You can view a list of Mohamed O. Ouf's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cavernous LymphangiomaMr. Ouf isExperienced. Learn about Cavernous Lymphangioma.
- Facial ParalysisMr. Ouf isExperienced. Learn about Facial Paralysis.
- Progressive Hemifacial AtrophyMr. Ouf isExperienced. Learn about Progressive Hemifacial Atrophy.